UNITED STATES SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C.

FORM D

OMB APPROVAL
OMB Number: 3235-0076
Estimated Average burden hours per response: 4.0
Notice of Exempt Offering of Securities


1. Issuer's Identity
CIK (Filer ID Number) Previous Name(s)   o None Entity Type
0001425205
Genesis Biopharma, Inc
FREIGHT MANAGEMENT CORP
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
  Lion Biotechnologies, Inc.
Jurisdiction of Incorporation/Organization
NEVADA
 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed  



2. Principal Place of Business and Contact Information
Name of Issuer  
  Lion Biotechnologies, Inc.  
Street Address 1 Street Address 2
  21900 BURBANK BLVD.   THIRD FLOOR
City State/Province/Country ZIP/Postal Code Phone No. of Issuer
  WOODLAND HILLS   CALIFORNIA   91367   818-992-3126  



3. Related Persons
Last Name First Name Middle Name
Singh Manish
Street Address 1 Street Address 2
21900 Burbank Blvd Third Floor
City State/Province/Country ZIP/Postal Code
WOODLAND HILLS CALIFORNIA 91367
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   
Last Name First Name Middle Name
Venkatesan Jay
Street Address 1 Street Address 2
21900 Burbank Blvd Third Floor
City State/Province/Country ZIP/Postal Code
WOODLAND HILLS CALIFORNIA 91367
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   
Last Name First Name Middle Name
Hillsberg Sanford
Street Address 1 Street Address 2
21900 Burbank Blvd Third Floor
City State/Province/Country ZIP/Postal Code
WOODLAND HILLS CALIFORNIA 91367
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   
Last Name First Name Middle Name
McPeak Merrill
Street Address 1 Street Address 2
21900 Burbank Blvd Third Floor
City State/Province/Country ZIP/Postal Code
WOODLAND HILLS CALIFORNIA 91367
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   
 
Last Name First Name Middle Name
Handelman Michael
Street Address 1 Street Address 2
21900 Burbank Blvd Third Floor
City State/Province/Country ZIP/Postal Code
WOODLAND HILLS CALIFORNIA 91367
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
   
 


4. Industry Group
o Agriculture   Health Care o Retailing
  Banking & Financial Services   x Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance   Technology
  o Insurance   o Hospitals & Physicians   o Computers
  o Investing   o Pharmaceuticals   o Telecommunications
  o Investment Banking   o Other Health Care   o Other Technology
  o Pooled Investment Fund

        Travel
  o Other Banking & Financial Services o Manufacturing   o Airlines & Airports
  Real Estate   o Lodging & Conventions
  o Commercial   o Tourism & Travel Services
  o Construction   o Other Travel
  o REITS & Finance o Other
  o Residential  
  o Other Real Estate  
o Business Services  
  Energy  
  o Coal Mining  
  o Electric Utilities  
  o Energy Conservation  
  o Environmental Services  
  o Oil & Gas  
  o Other Energy  


5. Issuer Size
Revenue Range Aggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale   2013-11-05 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
   


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary)  
   

11. Minimum Investment
Minimum investment accepted from any outside investor $   10000   USD

12. Sales Compensation
Recipient Recipient CRD Number o None
  Roth Capital Partners, LLC   15407
(Associated) Broker or Dealer x None (Associated) Broker or Dealer CRD Number x None
       
Street Address 1 Street Address 2
  888 San Clemente    
City State/Province/Country ZIP/Postal Code
  Newport Beach   CALIFORNIA   92660
State(s) of Solicitation o All States o Foreign/Non-US
  CALIFORNIA
 
Recipient Recipient CRD Number o None
  Scarsdale Equities LLC   134602
(Associated) Broker or Dealer x None (Associated) Broker or Dealer CRD Number x None
       
Street Address 1 Street Address 2
  10 Rockefeller Plaza   Suite 720
City State/Province/Country ZIP/Postal Code
  New York   NEW YORK   10020
State(s) of Solicitation o All States o Foreign/Non-US
  NEW YORK
 
Recipient Recipient CRD Number o None
  American Portfolio Financial Services, Inc.   18487
(Associated) Broker or Dealer x None (Associated) Broker or Dealer CRD Number x None
       
Street Address 1 Street Address 2
  4250 Veterans Memorial Hwy   Ste 420E
City State/Province/Country ZIP/Postal Code
  Holbrook   NEW YORK   11741
State(s) of Solicitation o All States o Foreign/Non-US
  ARIZONA
  CALIFORNIA
  COLORADO
  CONNECTICUT
  FLORIDA
  GEORGIA
  ILLINOIS
  INDIANA
  IOWA
  KENTUCKY
  MARYLAND
  MICHIGAN
  NEW JERSEY
  NEW MEXICO
  NEW YORK
  NORTH CAROLINA
  OHIO
  OREGON
  PENNSYLVANIA
  TENNESSEE
 
 
Recipient Recipient CRD Number o None
  Agincourt, Ltd.   36661
(Associated) Broker or Dealer x None (Associated) Broker or Dealer CRD Number x None
       
Street Address 1 Street Address 2
  3 Mill Creek Road    
City State/Province/Country ZIP/Postal Code
  Pembroke   BERMUDA   HM05
State(s) of Solicitation o All States x Foreign/Non-US
 
 



13. Offering and Sales Amounts
Total Offering Amount $   23290600   USD o Indefinite
Total Amount Sold $   23290600   USD  
Total Remaining to be Sold $   0   USD o Indefinite
 
Clarification of Response (if Necessary)
   


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 117


15. Sales Commissions & Finders' Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions $   1478437   USD o Estimate
Finders' Fees $   0   USD o Estimate
 
Clarification of Response (if Necessary)
  The Company also issued a total of 726,856 warrants to purchase the Company's common stock at $2.50 per share.


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
  $   0   USD x Estimate
 
Clarification of Response (if Necessary)
  Certain proceeds may be used for general working capital purposes which may include compensation and other payments to executive officers listed in Item 3.

Signature and Submission
Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.
Terms of Submission  
  In submitting this notice, each Issuer named above is:  
 
  • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, the information furnished to offerees.
  • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the Issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against it in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of: (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
  • Certifying that the Issuer is not disqualified from relying on any Regulation D exemption it has identified in Item 6 above for one of the reasons stated in Rule 505(b)(2)(iii).
 
 
  Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.
  For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

Issuer Signature Name of Signer Title Date
Lion Biotechnologies, Inc. /s/ Manish Singh Manish Singh Chief Executive Officer 2013-11-14